Hospital Juan Ramón Jiménez

Huelva 21005

0 studies enrolling now · 3 studies all time

What they study most

Amyloid Cardiomyopathy, Amyloidosis, Cardiomyopathies, Crohn Disease, Heart Diseases, Transthyretin Amyloidosis

Studies at this site

• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy — Completed
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed